Home-Based, Online, Mindfulness and Cognitive Training for Soldiers and Veterans With TBI
CogMind
2 other identifiers
interventional
23
1 country
1
Brief Summary
This study is a parallel arm, double-blind, randomized, controlled clinical trial to assess the safety and efficacy of an experimental software program designed to improve cognitive functions versus a computer-based software control. Both the study and the software being investigated meet the criteria of Non-Significant Risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2016
CompletedFirst Posted
Study publicly available on registry
October 4, 2016
CompletedStudy Start
First participant enrolled
March 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 14, 2020
CompletedDecember 23, 2025
December 1, 2025
3.4 years
September 29, 2016
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in performance on global cognitive composite score
Change in performance on global cognitive composite score based on the average of all normalized assessment measures.
At 3 months and at 6 months
Secondary Outcomes (8)
Changes in performance on processing speed composite score
At 3 months and at 6 months
Changes in performance on memory composite score
At 3 months and at 6 months
Changes in performance on executive function composite score
At 3 months and at 6 months
Change in functional performance
At 3 months and at 6 months
Change in TBI functional status
At 3 months and at 6 months
- +3 more secondary outcomes
Other Outcomes (12)
Change in Neurobehavioral Symptoms
At 3 months and at 6 months
Change in PTSD Symptoms
At 3 months and at 6 months
Change in Depressive Symptoms
At 3 months and at 6 months
- +9 more other outcomes
Study Arms (2)
Experimental Treatment
EXPERIMENTALComputerized plasticity-based adaptive cognitive training and mindfulness training requiring a total maximum of 60 treatment sessions, up to 5 sessions per week, 40 minutes per session.
Active Comparator
ACTIVE COMPARATORCommercially available computerized training and traumatic brain injury information session requiring a total maximum of 60 treatment sessions, up to 5 sessions per week, 40 minutes per session.
Interventions
Thirty minutes of training on computerized exercises that targets processing speed, memory and attention.
Thirty minutes of training on computerized, casual video games.
Ten minutes of using an online training course that teaches skills to help overcome ongoing life stressors.
Ten minutes of viewing traumatic brain injury related news, information, and programs.
Eligibility Criteria
You may qualify if:
- Participants must be 18 years of age or older
- Participants must have diagnosis of mild traumatic brain injury (mTBI) confirmed by Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF)
- Participants must have persistent cognitive dysfunction confirmed by an objective measure (Automated Neuropsychological Assessment Metrics (ANAM) TBI Battery with a score at least one standard deviation below the age-adjusted norm for a military sample) or a subjective measure (Ruff Neurobehavioral Inventory (RNBI) with a score of greater than 70 on any of the four cognitive scales (Attention, Memory, Language, Executive)
- Participants must be at least six months out from their most recent traumatic brain injury (TBI), concussion, and/or blast exposure
- Participant must be a fluent English speaker
- Participants must score ≥ 70 on the Wechsler Test of Adult Reading (WTAR)
- Participants must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse
You may not qualify if:
- Participants with history of TBI with loss of consciousness for more than 24 hours or post-traumatic amnesia for more than 7 days
- Participants with a history of penetrating head wounds
- Participants who are in-patients
- Participants with a diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis)
- Participants with active suicidal ideation with specific plan and intent or suicide-related behaviors within 2 months of consent as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Participants showing signs of intoxication due to current substance abuse (including alcohol and/or illegal drugs) during any in person visit
- Participants with clinically significant visual field deficits
- Participants judged to be lacking effort
- Participants with problems performing assessments or comprehending or following spoken instructions
- Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment for TBI that could affect the outcome of this study
- Participant with self-reported claustrophobia or physician-reported implanted devices (e.g. pacemakers, cochlear implants, aneurysm clips, etc.) and pregnant women will not be able to participate in MRI portion of study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Congressionally Directed Medical Research Programscollaborator
- Posit Science Corporationlead
- VA Connecticut Healthcare Systemcollaborator
Study Sites (1)
Veterans Affairs Connecticut Health Care System
West Haven, Connecticut, 06516, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyu Lee, PhD
Posit Science Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2016
First Posted
October 4, 2016
Study Start
March 31, 2017
Primary Completion
August 30, 2020
Study Completion
September 14, 2020
Last Updated
December 23, 2025
Record last verified: 2025-12